[144] Varex Imaging Corporation SEC Filing

Rhea-AI Filing Summary

Varex Imaging Corporation (VREX) Form 144 filing: An insider proposes to sell 3,000 shares of common stock through Fidelity Brokerage Services, with an aggregate market value of $31,470. The shares represent restricted stock that vested and were acquired on 02/13/2023 as compensation. The sale is scheduled for approximately 08/14/2025 on NASDAQ. The filer reports 41,500,000 shares outstanding for this class. The filer also disclosed a prior sale of 2,575 shares on 06/18/2025 for gross proceeds of $20,007.75. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.

Insights

Securities Analyst

TL;DR: Insider plans to sell a small block of vested restricted shares; transaction size appears immaterial versus outstanding shares.

The proposed sale of 3,000 common shares valued at $31,470 is a routine Rule 144 notification for vested compensation. Relative to 41.5 million shares outstanding, this sale is negligible and unlikely to affect market supply or valuation. The prior sale of 2,575 shares for $20,007.75 is consistent with modest insider liquidity. No earnings or operational details are disclosed here, so investor implications are limited to insider liquidity disclosure and compliance with Rule 144 requirements.

Corporate Governance Expert

TL;DR: Filing documents compliance with Rule 144; disclosure shows no undisclosed material information claimed by the seller.

This Form 144 provides required public notice of intended insider sales and confirms the shares were acquired via restricted stock vesting as compensation on 02/13/2023. The signature section includes the standard attestation about lack of material nonpublic information. From a governance perspective, the filing meets procedural expectations; it does not signal governance changes, extraordinary insider exits, or material dilution given the small size of the transactions relative to total shares outstanding.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	3000	31470.00	41500000	08/14/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/13/2023	Restricted Stock Vesting	Issuer			3000	02/13/2023	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Jay K. Kunkel 1678 S. Pioneer Road Salt Lake City UT 84104	Common	06/18/2025	2575	20007.75

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What transaction does the VREX Form 144 report?

The filing reports a proposed sale of 3,000 common shares acquired via restricted stock vesting on 02/13/2023, scheduled about 08/14/2025 on NASDAQ.

How much are the shares valued at in the Form 144 for VREX?

The aggregate market value reported is $31,470 for the 3,000 shares to be sold.

What prior insider sales are disclosed in this Form 144?

The filing discloses a sale on 06/18/2025 of 2,575 shares for gross proceeds of $20,007.75 by Jay K. Kunkel.

How large is the proposed sale relative to VREX's outstanding shares?

The filing lists 41,500,000 shares outstanding for the class; the 3,000-share sale is immaterial in proportion to outstanding shares.

Were the shares acquired as a gift or purchased?

The shares were acquired as compensation via restricted stock vesting and paid on 02/13/2023; no gift is indicated.